Platelet-derived HMGB1 is a critical mediator of thrombosis

Journal of Clinical Investigation

Volumn 125, Issue 12, 2015, Pages 4638-4654

  Vogel, Sebastian ^a,b   Bodenstein, Rebecca ^a   Chen, Qiwei ^b   Feil, Susanne ^a   Feil, Robert ^a   Rheinlaender, Johannes ^a   Schäffer, Tilman E ^a   Bohn, Erwin ^a   Frick, Julia Stefanie ^a   Borst, Oliver ^a   Münzer, Patrick ^a   Walker, Britta ^a   Markel, Justin ^b   Csanyi, Gabor ^c   Pagano, Patrick J ^c   Loughran, Patricia ^b   Jessup, Morgan E ^b   Watkins, Simon C ^b   Bullock, Grant C ^c   Sperry, Jason L ^b   Zuckerbraun, Brian S ^b   Billiar, Timothy R ^b   Lotze, Michael T ^b   Gawaz, Meinrad ^a   Neal, Matthew D ^b   more..

^a UNIVERSITY OF TÜBINGEN   (Germany)

^b UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^c UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIC GMP DEPENDENT PROTEIN KINASE 1; GUANYLATE CYCLASE; HIGH MOBILITY GROUP B1 PROTEIN; MYELOID DIFFERENTIATION FACTOR 88; TOLL LIKE RECEPTOR 4; HMGB1 PROTEIN, MOUSE; MYD88 PROTEIN, MOUSE; TLR4 PROTEIN, MOUSE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL GRANULE; CELL ISOLATION; CELL SPREADING; COMPLEX FORMATION; CONTROLLED STUDY; HEMORRHAGIC SHOCK; INFLAMMATION; MOUSE; NONHUMAN; ORGAN INJURY; PRIORITY JOURNAL; PROTEIN EXPRESSION; THROMBOCYTE; THROMBOCYTE ACTIVATION; THROMBOCYTE ADHESION; THROMBOCYTE AGGREGATION; THROMBOCYTE MEMBRANE; THROMBOSIS; UPREGULATION; ANIMAL; BLOOD CLOTTING; CELL MEMBRANE; GENETICS; METABOLISM; PATHOLOGY; TRANSGENIC MOUSE;

ANIMALS; BLOOD COAGULATION; BLOOD PLATELETS; CELL MEMBRANE; GUANYLATE CYCLASE; HMGB1 PROTEIN; MICE; MICE, TRANSGENIC; MYELOID DIFFERENTIATION FACTOR 88; PLATELET AGGREGATION; THROMBOSIS; TOLL-LIKE RECEPTOR 4;

EID: 84948807307     PISSN: 00219738     EISSN: 15588238     Source Type: Journal    
DOI: 10.1172/JCI81660     Document Type: Article

References (68)

1. Jackson SP. Arterial thrombosis-insidious, unpredictable and deadly. Nat Med. 2011;17(11):1423-1436.
2. Ruggeri ZM. Platelets in atherothrombosis. Nat Med. 2002;8(11):1227-1234.
3. Gawaz M, Langer H, May AE. Platelets in inflammation and atherogenesis. J Clin Invest. 2005;115(12):3378-3384.
4. Gawaz M, Vogel S. Platelets in tissue repair: control of apoptosis and interactions with regenerative cells. Blood. 2013;122(15):2550-2554.
5. Morrell CN, Aggrey AA, Chapman LM, Modjeski KL. Emerging roles for platelets as immune and inflammatory cells. Blood. 2014;123(18):2759-2767.
6. Nurden AT. Platelets, inflammation and tissue regeneration. Thromb Haemost. 2011;105(suppl 1):S13-S33.
7. Andersson U, Rauvala H. Introduction: HMGB1 in inflammation and innate immunity. J Intern Med. 2011;270(4):296-300.
8. Fiuza C, et al. Inflammation-promoting activity of HMGB1 on human microvascular endothelial cells. Blood. 2003;101(7):2652-2660.
9. Scaffidi P, Misteli T, Bianchi ME. Release of chro-matin protein HMGB1 by necrotic cells triggers inflammation. Nature. 2002;418(6894):191-195.
10. Vogel S, et al. Necrotic cell-derived high mobility group box 1 attracts antigen-presenting cells but inhibits hepatocyte growth factor-mediated tropism of mesenchymal stem cells for apoptotic cell death. Cell Death Differ. 2015;22(7):1219-1230.
11. Maugeri N, et al. Circulating platelets as a source of the damage-associated molecular pattern HMGB1 in patients with systemic sclerosis. Autoimmunity. 2012;45(8):584-587.
12. Rouhiainen A, Imai S, Rauvala H, Parkkinen J. Occurrence of amphoterin (HMG1) as an endogenous protein of human platelets that is exported to the cell surface upon platelet activation. Thromb Haemost. 2000;84(6):1087-1094.
13. Vogel S, et al. Activated platelets interfere with recruitment of mesenchymal stem cells to apop-totic cardiac cells via high mobility group box 1/Toll-like receptor 4-mediated down-regulation of hepatocyte growth factor receptor MET. J Biol Chem. 2014;289(16):11068-11082.
14. Goldstein RS, et al. Elevated high-mobility group box 1 levels in patients with cerebral and myocar-dial ischemia. Shock. 2006;25(6):571-574.
15. Kohno T, et al. Role of high-mobility group box 1 protein in post-infarction healing process and left ventricular remodelling. Cardiovasc Res. 2009;81(3):565-573.
16. Wang H, et al. HMG-1 as a late mediator of endotoxin lethality in mice. Science. 1999;285(5425):248-251.
17. Hatada T, et al. Plasma concentrations and importance of High Mobility Group Box protein in the prognosis of organ failure in patients with disseminated intravascular coagulation. Thromb Haemost. 2005;94(5):975-979.
18. Levy RM, et al. Systemic inflammation and remote organ injury following trauma require HMGB1. Am J Physiol Regul Integr Comp Physiol. 2007;293(4):R1538-R1544.
19. Venereau E, Schiraldi M, Uguccioni M, Bianchi ME. HMGB1 and leukocyte migration during trauma and sterile inflammation. Mol Immunol. 2013;55(1):76-82.
20. Fan J, et al. Hemorrhagic shock induces NAD(P)H oxidase activation in neutrophils: role of HMGB1-TLR4 signaling. J Immunol. 2007;178(10):6573-6580.
21. Huang H, et al. Damage-associated molecular pattern-activated neutrophil extracellular trap exacerbates sterile inflammatory liver injury. Hepatology. 2015;62(2):600-614.
22. Maugeri N, et al. Activated platelets present high mobility group box 1 to neutrophils, inducing autophagy promoting the extrusion of neu-trophil extracellular traps. J Thromb Haemost. 2014;12(12):2074-2088.
23. Ito T, et al. High-mobility group box 1 protein promotes development of microvascular thrombosis in rats. J Thromb Haemost. 2007;5(1):109-116.
24. Park JS, et al. High mobility group box 1 protein interacts with multiple Toll-like receptors. Am J Physiol Cell Physiol. 2006;290(3):C917-C924.
25. Park JS, et al. Involvement of toll-like receptors 2 and 4 in cellular activation by high mobility group box 1 protein. J Biol Chem. 2004;279(9):7370-7377.
26. Aslam R, et al. Platelet Toll-like receptor expression modulates lipopolysaccharide-induced thrombocytopenia and tumor necrosis factor-alpha production in vivo. Blood. 2006;107(2):637-641.
27. Fuentes E, Rojas A, Palomo I. Role of multilig-and/RAGE axis in platelet activation. Thromb Res. 2014;133(3):308-314.
28. Stark RJ, Aghakasiri N, Rumbaut RE. Platelet-derived Toll-like receptor 4 (Tlr-4) is sufficient to promote microvascular thrombosis in endo-toxemia. PLoS One. 2012;7(7):e41254.
29. Zhang G, et al. Lipopolysaccharide stimulates platelet secretion and potentiates platelet aggregation via TLR4/MyD88 and the cGMP-dependent protein kinase pathway. J Immunol. 2009;182(12):7997-8004.
30. Ding N, et al. Toll-like receptor 4 regulates platelet function and contributes to coagulation abnormality and organ injury in hemorrhagic shock and resuscitation. Circ Cardiovasc Genet. 2014;7(5):615-624.
31. Li Z, et al. A stimulatory role for cGMP-depen-dent protein kinase in platelet activation. Cell. 2003;112(1):77-86.
32. Li Z, Zhang G, Marjanovic JA, Ruan C, Du X. A platelet secretion pathway mediated by cGMP-dependent protein kinase. J Biol Chem. 2004;279(41):42469-42475.
33. Abrams ST, et al. Circulating histones are mediators of trauma-associated lung injury. Am J Respir Crit Care Med. 2013;187(2):160-169.
34. Gando S. Disseminated intravascular coagulation in trauma patients. Semin Thromb Hemost. 2001;27(6):585-592.
35. Kang R, et al. Intracellular Hmgb1 inhibits inflammatory nucleosome release and limits acute pancreatitis in mice. Gastroenterology. 2014;146(4):1097-1107.
36. Tiedt R, Schomber T, Hao-Shen H, Skoda RC. Pf4-Cre transgenic mice allow the generation of lineage-restricted gene knockouts for studying megakaryocyte and platelet function in vivo. Blood. 2007;109(4):1503-1506.
37. Li Z, Xi X, Du X. A mitogen-activated protein kinase-dependent signaling pathway in the activation of platelet integrin αIIbβ3. J Biol Chem. 2001;276(45):42226-42232.
38. Aszodi A, et al. The vasodilator-stimulated phosphoprotein (VASP) is involved in cGMP-and cAMP-mediated inhibition of agonist-induced platelet aggregation, but is dispensable for smooth muscle function. EMBO J. 1999;18(1):37-48.
39. Dostmann WR, Taylor MS, Nickl CK, Brayden JE, Frank R, Tegge WJ. Highly specific, mem-brane-permeant peptide blockers of cGMP-dependent protein kinase Iα inhibit NO-induced cerebral dilation. Proc Natl Acad Sci USA. 2000;97(26):14772-14777.
40. Andersson U, Tracey KJ. HMGB1 is a therapeutic target for sterile inflammation and infection. Annu Rev Immunol. 2011;29:139-162.
41. Nomura S, et al. The correlation between platelet activation markers and HMGB1 in patients with disseminated intravascular coagulation and hematologic malignancy. Platelets. 2011;22(5):396-397.
42. Ahrens I, et al. HMGB1 binds to activated platelets via the receptor for advanced glycation end products and is present in platelet rich human coronary artery thrombi. Thromb Haemost. 2015;114(5):994-1003.
43. Elvers M, et al. Intracellular cyclophilin A is an important Ca(2+) regulator in platelets and critically involved in arterial thrombus formation. Blood. 2012;120(6):1317-1326.
44. Seizer P, et al. Extracellular cyclophilin A activates platelets via EMMPRIN (CD147) and PI3K/Akt signaling, which promotes platelet adhesion and thrombus formation in vitro and in vivo. Arterioscler Thromb Vasc Biol. 2014;35(3):655-663.
45. Boudreau LH, et al. Platelets release mitochondria serving as substrate for bactericidal group IIA-secreted phospholipase A2 to promote inflammation. Blood. 2014;124(14):2173-2183.
46. Chatterjee M, et al. Macrophage migration inhibitory factor limits activation-induced apoptosis of platelets via CXCR7-dependent Akt signaling. Circ Res. 2014;115(11):939-949.
47. Vogel S, Rath D, Lu J, Chatterjee M, Geisler T, Gawaz M. Elevated mitochondrial membrane potential of circulating monocyte-platelet aggregates in patients with coronary heart disease. Int J Cardiol. 2014;181:135-137.
48. Neal MD, et al. Prehospital use of nonsteroidal anti-inflammatory drugs (NSAIDs) is associated with a reduced incidence of trauma-induced coagulopathy. Ann Surg. 2014;260(2):378-382.
49. Gill R, et al. Systemic inflammation and liver injury following hemorrhagic shock and peripheral tissue trauma involve functional TLR9 signaling on bone marrow-derived cells and par-enchymal cells. Shock. 2011;35(2):164-170.
50. Caudrillier A, et al. Platelets induce neutrophil extracellular traps in transfusion-related acute lung injury. J Clin Invest. 2012;122(7):2661-2671.
51. Fuchs TA, et al. Extracellular DNA traps promote thrombosis. Proc Natl Acad Sci USA. 2010;107(36):15880-15885.
52. Huang H, et al. Hepatocyte-specific high-mobility group box 1 deletion worsens the injury in liver ischemia/reperfusion: a role for intracellular high-mobility group box 1 in cellular protection. Hepatology. 2014;59(5):1984-1997.
53. Yanai H, et al. Conditional ablation of HMGB1 in mice reveals its protective function against endotoxemia and bacterial infection. Proc Natl Acad Sci USA. 2013;110(51):20699-20704.
54. Zhu X, et al. Cytosolic HMGB1 controls the cellular autophagy/apoptosis checkpoint during inflammation. J Clin Invest. 2015;125(3):1098-1110.
55. Andrassy M, et al. High-mobility group box-1 in ischemia-reperfusion injury of the heart. Circulation. 2008;117(25):3216-3226.
56. Tsung A, et al. The nuclear factor HMGB1 mediates hepatic injury after murine liver ischemia-reperfu-sion. J Exp Med. 2005;201(7):1135-1143.
57. Rheinlaender J, et al. Imaging the elastic modulus of human platelets during thrombin-induced activation using scanning ion conductance microscopy. Thromb Haemost. 2015;113(2):305-311.
58. Massberg S, et al. Increased adhesion and aggregation of platelets lacking cyclic gua-nosine 3′, 5′-monophosphate kinase I. J Exp Med. 1999;189(8):1255-1264.
59. Zhang G, et al. Biphasic roles for soluble guany-lyl cyclase (sGC) in platelet activation. Blood. 2011;118(13):3670-3679.
60. Cai C, et al. Benzyl alcohol attenuates acetamin-ophen-induced acute liver injury in a Toll-like receptor-4-dependent pattern in mice. Hepatology. 2014;60(3):990-1002.
61. Sodhi C, et al. DNA attenuates enterocyte Tolllike receptor 4-mediated intestinal mucosal injury after remote trauma. Am J Physiol Gastroin-test Liver Physiol. 2011;300(5):G862-G873.
62. Geisel J, et al. IL-6 and maturation govern TLR2 and TLR4 induced TLR agonist tolerance and cross-tolerance in dendritic cells. J Immunol. 2007;179(9):5811-5818.
63. Yazji I, et al. Endothelial TLR4 activation impairs intestinal microcirculatory perfusion in necrotizing enterocolitis via eNOS-NO-nitrite signaling. Proc Natl Acad Sci USA. 2013;110(23):9451-9456.
64. Weber S, et al. Rescue of cGMP kinase I knockout mice by smooth muscle specific expression of either isozyme. Circ Res. 2007;101(11):1096-1103.
65. Feil R, Lohmann SM, de Jonge H, Walter U, Hofmann F. Cyclic GMP-dependent protein kinases and the cardiovascular system: insights from genetically modified mice. Circ Res. 2003;93(10):907-916.
66. Choudhri TF, et al. Reduced microvascular thrombosis and improved outcome in acute murine stroke by inhibiting GP IIb/IIIa receptor-mediated platelet aggregation. J Clin Invest. 1998;102(7):1301-1310.
67. Darwiche SS, Kobbe P, Pfeifer R, Kohut L, Pape HC, Billiar T. Pseudofracture: an acute peripheral tissue trauma model. J Vis Exp. 2011;(50):2074.
68. Lee D, Fong KP, King MR, Brass LF, Hammer DA. Differential dynamics of platelet contact and spreading. Biophys J. 2012;102(3):472-482.